Abstract：Objective: To explore the effect of pharmaceutical guidance based on evidence-based support for the prognosis of patients with type 2 diabetes mellitus. Methods: 140 patients with type 2 diabetes admitted to our hospital were randomly divided into two groups according to envelope method. 70 patients in the control group were given routine medication guidance, while 70 patients in the observation group were given pharmaceutical guidance based on evidence-based support. The interventions of the two groups were compared. Results: Compared with the control group, the fasting blood sugar, 2-hour postprandial blood sugar and glycosylated hemoglobin levels in the observation group were better than those in the control group (p < 0.05). Secondly, the incidence of adverse reactions and medication deviation in the observation group was lower than that in the control group (p < 0.05). Thirdly, the compliance analysis showed that the observation group was significantly higher than the control group (p < 0.05). Group (p<0.05). Conclusion: Pharmaceutical guidance based on evidence-based support is effective in improving drug safety, blood sugar control and drug compliance of patients with type 2 diabetes mellitus, and can be popularized.
梁志国, 苟欣. 循证支持下药学指导对2型糖尿病患者预后的指导意义[J]. 河北医学, 2019, 25(6): 1045-1047.
LIANG Zhiguo, GOU Xin. Guiding Significance of Pharmacy Guidance based on Evidence-based Support for Prognosis of Patients with Type 2 Diabetes Mellitus. HeBei Med, 2019, 25(6): 1045-1047.
[1] 王超.临床药师指导患者临床用药进展分析[J].继续医学教育,2017,31(10):159~160. [2] 张秀娟.药学指导对糖尿病患者用药依从性及疾病知晓率的影响[J].中医临床研究,2017,9(19):135~136. [3] Unwin N, Alberti K G M M, Bhopal R, et al. Comparison of the current WHO and new ADA criteria for the diagnosis of diabetes mellitus in three ethnic groups in the UK[J]. Diabet Med, 2015, 15(7):554~557. [4] Inzucchi S E, Bergenstal R M, Buse J B, et al. Management of Hyperglycemia in type 2 diabetes, 2015: a patient-centered approach: update to a position statement of the american diabetes association and the european association for the study of diabetes[J]. Diabetes Care, 2015, 38(1):140~149. [5] 曾晓红,吴涤心,傅存冀.药学干预对2型糖尿病患者用药依从性及药品不良反应的影响[J].中国医院用药评价与分析,2016,16(1):124~126. [6] 姜雪莲,白国欣,胡晨萍.延续护理对2型糖尿病患者自我认知能力与遵医行为的影响[J].医学研究与教育,2018,35(1):76~80
2019, Vol. 25 
冀公网安备13080202000677号